within Pharmacolibrary.Drugs.ATC.A;

model A11CC04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.33 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Calcitriol is the hormonally active form of vitamin D3 (1,25-dihydroxycholecalciferol), used in the management of hypocalcemia and bone disorders associated with chronic renal failure, hypoparathyroidism, and some other conditions. It is approved and commonly used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics of calcitriol in healthy adult volunteers following single intravenous dose administration.</p><h4>References</h4><ol><li><p>Levine, BS, &amp; Song, M (1996). Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. <i>Journal of the American Society of Nephrology : JASN</i> 7(3) 488–496. DOI:<a href=&quot;https://doi.org/10.1681/ASN.V73488&quot;>10.1681/ASN.V73488</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8704116/&quot;>https://pubmed.ncbi.nlm.nih.gov/8704116</a></p></li><li><p>Muindi, JR, et al., &amp; Fakih, MG (2009). A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors. <i>Cancer chemotherapy and pharmacology</i> 65(1) 33–40. DOI:<a href=&quot;https://doi.org/10.1007/s00280-009-1000-2&quot;>10.1007/s00280-009-1000-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19396601/&quot;>https://pubmed.ncbi.nlm.nih.gov/19396601</a></p></li><li><p>Muindi, JR, et al., &amp; Trump, DL (2002). Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. <i>Clinical pharmacology and therapeutics</i> 72(6) 648–659. DOI:<a href=&quot;https://doi.org/10.1067/mcp.2002.129305&quot;>10.1067/mcp.2002.129305</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12496746/&quot;>https://pubmed.ncbi.nlm.nih.gov/12496746</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A11CC04;
